Rigel Pharmaceuticals: Q4 Earnings Insights
Rigel Pharmaceuticals: Q4 Earnings Insights
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:01 PM.
銳傑製藥（納斯達克股票代碼：RIGL）於2024年3月5日星期二下午4點01分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Rigel Pharmaceuticals beat estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $-0.03.
瑞格製藥比預期收益高出100.0％，每股收益爲0.0美元，而估計爲-0.03美元。
Revenue was down $15.49 million from the same period last year.
收入比去年同期下降了1,549萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.04 which was followed by a 2.0% increase in the share price the next day.
上個季度，該公司的每股收益高出0.04美元，隨後第二天股價上漲了2.0％。
Here's a look at Rigel Pharmaceuticals's past performance:
以下是銳佳製藥過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.08 | -0.10 | -0.11 |
| EPS Actual | -0.03 | -0.04 | -0.08 | 0.01 |
| Revenue Estimate | 27.20M | 26.02M | 24.07M | 27.97M |
| Revenue Actual | 28.13M | 26.89M | 26.07M | 51.28M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.07 | -0.08 | -0.10 | -0.11 |
| 實際每股收益 | -0.03 | -0.04 | -0.08 | 0.01 |
| 收入估算 | 27.20 米 | 26.02 米 | 24.07 億 | 27.97 億 |
| 實際收入 | 28.13 億 | 26.89 億 | 26.07 億 | 51.28 億 |
To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.
要追蹤銳佳製藥公司發佈的所有業績，請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。